Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-075930
Filing Date
2011-08-11
Accepted
2011-08-11 10:11:40
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b82747e10vq.htm 10-Q 205888
2 EX-31.1 b82747exv31w1.htm EX-31.1 8035
3 EX-31.2 b82747exv31w2.htm EX-31.2 8109
4 EX-32.1 b82747exv32w1.htm EX-32.1 2654
5 EX-32.2 b82747exv32w2.htm EX-32.2 2735
  Complete submission text file 0000950123-11-075930.txt   1443339

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT alse-20110630.xml EX-101.INS 129784
7 EX-101 SCHEMA DOCUMENT alse-20110630.xsd EX-101.SCH 12799
8 EX-101 CALCULATION LINKBASE DOCUMENT alse-20110630_cal.xml EX-101.CAL 34758
9 EX-101 LABELS LINKBASE DOCUMENT alse-20110630_lab.xml EX-101.LAB 133309
10 EX-101 PRESENTATION LINKBASE DOCUMENT alse-20110630_pre.xml EX-101.PRE 79847
11 EX-101 DEFINITION LINKBASE DOCUMENT alse-20110630_def.xml EX-101.DEF 17968
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

EIN.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-06533 | Film No.: 111026217
SIC: 2834 Pharmaceutical Preparations